Biologic and quality-of-life outcomes from the Mediterranean Lifestyle Program: A randomized clinical trial

Diabetes Care

Volumn 26, Issue 8, 2003, Pages 2288-2293

  Toobert, Deborah J ^a   Glasgow, Russell E ^b   Strycker, Lisa A ^a   Barrera Jr , Manuel ^c   Radcliffe, Janice L ^d   Wander, Rosemary C ^e   Bagdade, John D ^a  

^a OREGON RESEARCH INSTITUTE   (United States)

^b Clinical Research Unit   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF OREGON   (United States)

^e UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; LOW FAT DIET; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; SUPPORT GROUP; TRAINING;

AGED; BLOOD PRESSURE; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIET, MEDITERRANEAN; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MIDDLE AGED; PATIENT DROPOUTS; POSTMENOPAUSE; QUALITY OF LIFE; RISK FACTORS; RISK REDUCTION BEHAVIOR; SELF CARE; TREATMENT OUTCOME;

EID: 0042023793     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.8.2288     Document Type: Article

References (25)

1. Beckles GLA, Thompson-Reid PE (Eds.): Diabetes and Women's Health Across the Life Stages: A Public Health Perspective. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation, 2001
2. Hoyert DL, Kochanek KD, Murphy SL: Deaths: final data for 1997. Natl Vital Stat Rep 48:1-105, 2000
3. Haffner SM, Lehto S, Ronnemaa T, Pvorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
4. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC: Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 343:16-22, 2000
5. Lee IM, Rexrode KM, Cook NR, Manson JE, Buring JE: Physical activity and coronary heart disease in women. JAMA 285:1447-1454, 2001
6. Carroll JF, Kyser CK: Exercise training in obesity lowers blood pressure independent of weight change. Med Sci Sports Exerc 34:596-601, 2002
7. Macleod J, Davey-Smith G, Heslop P, Metcalfe C, Carroll D, Hart C: Limitations of adjustment for reporting tendency in observational studies of stress and self reported coronary heart disease. J Epidemiol Comm Health 56:76-77, 2002
8. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
9. Toobert DJ, Strycker LA, Glasgow RE: Lifestyle change in women with coronary heart disease: what do we know? J Women Health 7:685-699, 1998
10. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin J-L, Monjaud I, Guidollet J, Touboul P, Delaye J: Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343:1454-1459, 1994
11. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
12. Toobert DJ, Glasgow RE, Radcliffe JL: Physiologic and related behavioral outcomes from the Women's Lifestyle Heart Trial. Ann Behav Med 22:1-9, 2000
13. Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko R, Williams PT, Johnstone IM, Champagne MA, Krauss RM: Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: the Stanford Coronary Risk Intervention Project (SCRIP). Circulation 89:975-990, 1994
14. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL: Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 336:129-133, 1990
15. Fair JM, Haskell WL: The effect of intensive coronary risk reduction on psychosocial and health-related quality of life resources. Journal of Prevention and Intervention in the Community 13:71-89, 1996
16. a. Toobert DJ, Strycker LA, Glasgow RE, Bagdade JD: If you build it, will they come? Reach and adoption associated with a comprehensive lifestyle management program for women with type 2 diabetes. Patient Educ Counsel 1646:1-7, 2002
17. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D, Ettinger W, Heath GW, King AC: Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 273:402-407, 1995
18. An P, Rice T, Gagnon J, Borecki IB, Pérusse L, Leon AS, Skinner JS, Wilmore JH, Bouchard C, Rao DC: Familial aggregation of resting blood pressure and heart rate in a sedentary population: the HERITAGE Family Study: Health, Risk Factors, Exercise Training and Genetics. Am J Hpertens 12:264-270, 1999
19. MacDougall DJ, Wenger HA, Green HJ: Physiological Testing of Elite Athletes, Ithaca, NY, Movement Publications, 1983
20. Stewart AL, Hays RD, Ware JE Jr: The MOS short-form general health survey: reliability and validity in a patient population. Med Care 26:724-735, 1988
21. Polonsky WH: Understanding and assessing diabetes-specific quality of life. Diabetes Spectrum 13:36-41, 2000
22. American Diabetes Association: Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 26 (Suppl. 1):S28-S32, 2003
23. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, Hunter D, Manson JE: Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 287:1815-1821, 2002
24. Ornish D: Dr. Dean Ornish's Program for Reversing Heart Disease. New York, Ballantine Books, 1990
25. Glasgow RE, McKay HG, Piette JD, Reynolds KD: The RE-AlM framework for evaluating interventions: what can it tell us about approaches to chronic illness management? Patient Educ Couns 44:119-127, 2001